Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
JV will accelerate expansion of Lands’ End’s growth into new categories, channels, and internationally, by leveraging WHP Global’s best-in-class platform $300M in gross proceeds to Lands’ End enables...
-
Cellcosmet introduces Hydra-Soothing Mask to calm and support sensitive and post-procedure skin, reducing redness and strengthening the barrier.
-
Paragonix Technologies will feature oral presentations and poster sessions at ISHLT 2026, showcasing clinical data related to its heart and lung preservation devices.The extensive research being...
-
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medpace Holdings, Inc., (“Medpace" or the "Company") (NASDAQ:MEDP) investors that the firm has initiated an investigation...
-
CALABASAS, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing...
-
SOUTH SAN FRANCISCO, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene...
-
PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ:...
-
Geneva, Switzerland / Sanand, Gujarat, India, April 01, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a leader in semiconductor, PKI, and post-quantum technology...
-
WESTMINSTER, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Highridge Medical, a leading privately held global spine company with a portfolio supported by extensive clinical evidence, announced that,...
-
MISSISSAUGA, Ontario, April 01, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® has been named the #1 recommended over-the-counter (OTC)...